ETF overview
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
Current price
41.53 USD-0.14%
Close 21 Oct 2026Interval
BenchmarksFund facts
- Expense ratio
- 0.99%
- Fund assets
- 212.14M USD (all share classes)
- Issuer
- Tema
- Inception date
- Aug 14, 2023
- Number of holdings
- 58
Breakdown
Holdings (58)
| Name | Ticker | Weight |
|---|---|---|
| MERCK & CO INC | MRK | 5.61% |
| REVOLUTION MEDICINES INC | RVMD | 5.19% |
| ELI LILLY & CO | LLY | 5.06% |
| COGENT BIOSCIENCES INC | COGT | 4.60% |
| NOVARTIS AG | NOVN.SW | 4.10% |
| ABBVIE INC | ABBV | 3.82% |
| GENMAB A/S | GMAB | 3.78% |
| BEONE MEDICINES LTD | ONC | 3.72% |
| HALOZYME THERAPEUTICS INC | HALO | 3.61% |
| EXELIXIS INC | EXEL | 3.49% |
| and 45 more | ||
Similar ETFs
- Tema Heart & Health ETFHRTS · Overlap 32% · Expense ratio 0.99%
- Portfolio Building Block World Pharma and Biotech Index ETFPBPH · Overlap 31% · Expense ratio 0.13%
- BetaShares - Global Healthcare Currency Hedged ETFDRUG.AX · Overlap 32% · Expense ratio 0.57%
Overlap is the share of assets the two funds hold in common.
Historical returns do not guarantee future returns. This is not investment advice.
Benchmarks
Fund facts
- Expense ratio
- 0.99%
- Fund assets
- 212.14M USD (all share classes)
- Issuer
- Tema
- Inception date
- Aug 14, 2023
- Number of holdings
- 58
Breakdown
Holdings (58)
| Name | Ticker | Weight |
|---|---|---|
| MERCK & CO INC | MRK | 5.61% |
| REVOLUTION MEDICINES INC | RVMD | 5.19% |
| ELI LILLY & CO | LLY | 5.06% |
| COGENT BIOSCIENCES INC | COGT | 4.60% |
| NOVARTIS AG | NOVN.SW | 4.10% |
| ABBVIE INC | ABBV | 3.82% |
| GENMAB A/S | GMAB | 3.78% |
| BEONE MEDICINES LTD | ONC | 3.72% |
| HALOZYME THERAPEUTICS INC | HALO | 3.61% |
| EXELIXIS INC | EXEL | 3.49% |
| and 45 more | ||
ETF overview
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
- Tema Heart & Health ETFHRTS · Overlap 32% · Expense ratio 0.99%
- Portfolio Building Block World Pharma and Biotech Index ETFPBPH · Overlap 31% · Expense ratio 0.13%
- BetaShares - Global Healthcare Currency Hedged ETFDRUG.AX · Overlap 32% · Expense ratio 0.57%
Overlap is the share of assets the two funds hold in common.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free